lypressin has been researched along with Acute Respiratory Distress Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Lu, Y; Yang, C; Zhou, P | 1 |
| Aydogan, M; Balta, S; Demirkol, S; Gumus, S | 1 |
| Hua, F; Wang, X; Zhu, L | 1 |
| Araújo, LV; Freitas, GG; Martins, GA; Salluh, JI; Santino, MS; Verdeal, JC | 1 |
2 trial(s) available for lypressin and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
[Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial].
Topics: Berlin; Hemodynamics; Humans; Lypressin; Norepinephrine; Prospective Studies; Respiratory Distress Syndrome; Shock, Septic; Single-Blind Method; Terlipressin | 2017 |
Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock.
Topics: Blood Pressure; Dopamine; Dopamine Agents; Female; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Prospective Studies; Respiratory Distress Syndrome; Shock, Septic; Terlipressin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2013 |
2 other study(ies) available for lypressin and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
The Pivotal Roles of Risk Factors for Acute Respiratory Distress Syndrome.
Topics: Female; Humans; Lypressin; Male; Respiratory Distress Syndrome; Shock, Septic; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2016 |
Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
Topics: Accidents, Traffic; Adolescent; Blood Pressure; Brain Injuries; Catecholamines; Cerebrovascular Circulation; Drug Resistance; Fatal Outcome; Humans; Lypressin; Male; Motorcycles; Multiple Organ Failure; Norepinephrine; Oxygen; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Time Factors; Vasoconstrictor Agents | 2007 |